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Wall teichoic acids (WTAs) are anionic polymers that
play key roles in bacterial cell shape, cell division,
envelope integrity, biofilm formation, and pathogen-
esis. B. subtilisW23 and S. aureus both make polyri-
bitol-phosphate (RboP) WTAs and contain similar
sets of biosynthetic genes. We use in vitro reconsti-
tution combined with genetics to show that the path-
ways for WTA biosynthesis in B. subtilis W23 and
S. aureus are different. S. aureus requires a glyc-
erol-phosphate primase called TarF in order to
make RboP-WTAs; B. subtilis W23 contains a TarF
homolog, but this enzyme makes glycerol-phos-
phate polymers and is not involved in RboP-WTA
synthesis. Instead, B. subtilis TarK functions in place
of TarF to prime the WTA intermediate for chain
extension by TarL. This work highlights the enzy-
matic diversity of the poorly characterized family of
phosphotransferases involved in WTA biosynthesis
in Gram-positive organisms.
INTRODUCTION
Teichoic acids are highly abundant anionic polymers found in
Gram-positive bacteria. There are two types of teichoic acids:
the lipoteichoic acids (LTAs), which are embedded in the bacte-
rial membrane and extend into the peptidoglycan layers; and the
wall teichoic acids (WTAs), which are covalently attached to the
peptidoglycan layers and extend beyond them (Figure 1A)
(Neuhaus and Baddiley, 2003). Teichoic acids play important
but as yet poorly understood roles in cell shape determination
(D’Elia et al., 2006a; Pollack and Neuhaus, 1994; Soldo et al.,
2002), cell division (Grundling and Schneewind, 2007; Oku
et al., 2009; Schirner et al., 2009), biofilm formation (Fabretti
et al., 2006; Fedtke et al., 2007; Vergara-Irigaray et al., 2008),
cell adhesion (Gross et al., 2001; Weidenmaier et al., 2004),
and other aspects of Gram-positive physiology (Swoboda
et al., 2010; Xia et al., 2009). Although neither type of teichoic
acid is strictly essential for survival in vitro, organisms lacking
either one display growth defects that range frommild to severe.
Furthermore, it has been shown that pathogenicity is criticallyChemistry & Biology 17, 1101–1dependent on the expression ofWTAs inS. aureus (Weidenmaier
et al., 2004, 2005). A detailed understanding of WTA biosyn-
thesis is important for exploring their roles in bacterial physiology
and assessing their potential as antibacterial targets (May et al.,
2005; Swoboda et al., 2009).
WTAs are attached via a phosphodiester linkage to the
N-acetyl muramic acid sugars of peptidoglycan. WTAs typically
consist of a disaccharide linkage unit followed by a polymeric
main chain (Figure 1B). The B. subtilis W23 main chain is
structurally identical to the main chain in S. aureus and contains
ribitol-5-phosphate (RboP) repeats (Swoboda et al., 2010).
As shown in Figure 1C, a pathway for polyribitol phosphate
WTA synthesis was proposed many years ago by Lazarevic
et al. (2002). This model was based on comparing the genes
for WTA biosynthesis in B. subtilisW23 to the genes in B. subtilis
168, which makes polyglycerol-phosphate WTAs (Neuhaus and
Baddiley, 2003; Ward, 1981). Previous studies have confirmed
the proposed functions of the first three steps in the RboP-WTA
biosynthetic pathway. The first enzyme in this pathway, TagO, is
an integral membrane protein that transfers phospho-GlcNAc
from UDP-GlcNAc to an undecaprenyl carrier lipid embedded
in the cytoplasmic surface of the bacterial membrane (D’Elia
et al., 2006b; Weidenmaier et al., 2004). The lipid-linked
monosaccharide is then converted to disaccharide 4 by the
UDP-ManNAc transferase TagA (Brown et al., 2008; D’Elia
et al., 2009; Zhang et al., 2006). A primase, TagB, then attaches
a single glycerol-phosphate (GroP) unit to the nonreducing end
of the disaccharide (Brown et al., 2008). Following assembly of
the disaccharide linkage unit, the pathway for polyRboP-WTAs
was proposed to require three enzymes (TarF, TarK, and TarL)
to complete the polymeric main chain (Lazarevic et al., 2002).
The proposed functions of these three enzymes are shown in
Figure 1C. OnceWTA synthesis is complete, the RboP polymers,
still attached to the undecaprenyl carrier lipid, are flipped to the
external surface of the membrane where they are attached to
peptidoglycan (Swoboda et al., 2010).
Recent studies have shown that polyRboP-WTA polymer
synthesis in S. aureus differs from the proposed pathway in
Figure 1C in that only two enzymes are required to complete the
polyRboP main chain (Brown et al., 2008; Meredith et al., 2008;
Pereiraet al., 2008a).Oneenzyme isTarF (TarFSa),which transfers
a single GroP to the linkage unit. The other enzyme is TarL, which
combines the proposed functions of TarK and TarL shown in
Figure 1C. That is, S. aureus TarL (TarLSa) is a ribitol-phosphate110, October 29 , 2010 ª2010 Elsevier Ltd All rights reserved 1101
Figure 1. Teichoic Acids Are a Major
Component of the Gram-Positive Cell
Wall, and the Pathway for Ribitol-Phos-
phate WTAs Has Been Proposed
(A) A schematic of the Gram-positive cell wall de-
picting membrane-anchored LTA and peptido-
glycan-anchored WTA polymers.
(B) The chemical structure of ribitol-phosphate
WTA as found in S. aureus and B. subtilis W23
(y = 1–2, z = 20–40). The tailoring modifications
on themain chain hydroxyls are omitted for clarity.
(C) Lazarevic et al. (2002) proposed the biosyn-
thetic pathway depicted above for polyribitol-
phosphate WTAs. The numbers in parentheses
correspond to the substrates utilized in our
in vitro experiments (see Figure 2 for chemical
structures).
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Pathway for B. subtilis W23 WTA Biosynthesispolymerase that can act directly on the TarF product without
requiring a RboP-primed substrate. It functions to prime and
extend the elaborated linkage unit (5) (Brown et al., 2008).
Although we have shown that S. aureus contains two copies of
tarL (one of which was the originally proposed TarK), only one of
these copies is essential in cells (Meredith et al., 2008; Swoboda
et al., 2010). These discovered differencesbetween theproposed
anddemonstratedS. aureusWTApathway prompted us to inves-
tigate the WTA biosynthetic pathway for B. subtilis W23, the
organismonwhich thepathwayshown inFigure1C forpolyRboP-
WTA biosynthesis is based. We show here that the B. subtilis
pathway differs in several ways from the S. aureus pathway,
even though both organisms make a polyribitol-phosphate WTA
polymer. Furthermore, it differs from the previously proposed B.
subtilis pathway.
RESULTS
Description of the Approach
As described in the Introduction, WTA precursors are synthe-
sized in the cytoplasm on an undecaprenyl phosphate-carrier
lipid embedded in the membrane (Swoboda et al., 2010).
The first enzyme in the WTA biosynthetic pathway, TagO, is an
integral membrane protein, but many of the other enzymes
involved in the assembly of the WTA polymer do not have pre-
dicted membrane-spanning regions, although it is presumed
that they are membrane-associated either directly or indirectly
(Bhavsar et al., 2007; Formstone et al., 2008). Membrane-
associated enzymes in other lipid carrier-mediated biosynthetic
pathways (e.g., peptidoglycan biosynthesis) will accept water-
soluble substrates containing truncated lipid chains in the
absence of biological membranes or membrane mimics (Chen
et al., 2002, 2007; Faridmoayer et al., 2008; May et al., 2009;
Men et al., 1998; Ye et al., 2001). Therefore, we synthesized
WTA pathway intermediates containing short lipid chains and
have previously shown that these intermediates are functional1102 Chemistry & Biology 17, 1101–1110, October 29 , 2010 ª2010 Elsevier Ltd All rights ressubstrates for several WTA enzymes
in vitro (Brown et al., 2008; Ginsberg
et al., 2006; Zhang et al., 2006). Here,
we use the short chain substrate analogs
shown in Figure 3 to characterize the latesteps of polyribitol-phosphate WTA biosynthesis in B. subtilis
W23. As described later, analysis of the products formed
in vitro by B. subtilis TarF (TarFBs), combined with the in vitro
substrate preferences for B. subtilis TarK (TarKBs), suggested
a revised pathway for polyRboP-WTA biosynthesis in B. subtilis
W23. Using genetic approaches, we have confirmed the revised
B. subtilis W23 WTA biosynthetic pathway.
Biochemical Reconstitution of B. subtilisW23 TarF
and Comparison to S. aureus TarF
The first three steps in the pathways for WTA synthesis in
B. subtilis W23 and S. aureus are identical and lead to the
production of lipid-pp-GlcNAc-ManNAc-GroP (compound 4)
(Figure 1C). We have shown that S. aureus TarF is a primase
that adds a single glycerol phosphate unit to 4 to produce
lipid-pp-GlcNAc-ManNAc-GroP2 (compound 5) (Brown et al.,
2008). The function of TarF in B. subtilis W23 has not previously
been studied, but it was proposed, like its S. aureus ortholog, to
act as a GroP primase (Lazarevic et al., 2002), which catalyzes
the reaction of 4with CDP-glycerol (1) to formWTA intermediate
5. To test this prediction, we cloned and expressed B. subtilis
W23 TarF (TarFBs) as a C-terminal 6-His fusion from genomic
DNA and purified it via Ni2+ chromatography. We incubated
purified TarFBs with radiolabeled 4b in the presence of
[14C]-CDP-glycerol (1) and analyzed the results by polyacryl-
amide gel electrophoresis. PAGE analysis showed that
CDP-glycerol (1) reacted in the presence of TarFBs and lipid-
pp-GlcNAc-ManNAc-GroP (4b) to generate a new radioactive
spot (see Figure S1A available online); see below for product
identification. TarFBs under the same conditions did not react
with 1 and 3b, or with CDP-ribitol (2) and 4b. These results sug-
gested that TarFBs, like its S. aureus counterpart, catalyzes the
addition of GroP, but not ribitol-phosphate, to primed substrate
4, but not to the unprimed precursor 3.
We next analyzed the products formed by the reaction of
radiolabeled 1 and 4b in the presence of TarFBs. For comparisonerved
Figure 2. Structures of WTA Substrates and Intermediates
The structures of the CDP-glycerol (1) and CDP-ribitol (2) donor and lipid acceptor substrates 3, 4, 5, 6, and 7 are shown. The natural acceptor substrates contain
an undecaprenyl chain. Substrates having the ‘‘a’’ suffix contain a neryl chain andwere used for LC/MSanalysis; substrates having the ‘‘b’’ suffix contain a farnesyl
chain and were used for PAGE analysis. Synthesis of substrates and incorporation of [14C] radiolabels for PAGE analysis were carried out as described previously
(Brown et al., 2008).
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Pathway for B. subtilis W23 WTA Biosynthesisthe same substrates were also incubated with S. aureus TarF
(TarFSa). Products were analyzed via PAGE (Figures 3B and
3C). TarFSa produces a single well-resolved product, identified
by exact mass analysis of a nonradioactive reaction as lipid-
pp-GlcNAc-ManNAc-GroP2 (compound 5); this product corre-
sponds to the transfer of a single GroP unit to 4. Under forcingFigure 3. TarF Is a Polymerase in B. subtilis W23 and a Primase in S. a
(A) Reaction carried out by TarF (n = 3–9 for TarFBs; n = 2 for TarFSa).
(B andC) PAGE analysis of TarFBs (B) and TarFSa (C) reactions using 1 and substrat
of purified TarF reaction products using substrate 4a are shown.
Chemistry & Biology 17, 1101–1conditions (high enzyme and substrate concentrations for
prolonged reaction times), an additional product containing
three GroP units (compound 6) can also be observed (Fig-
ure S2A). In marked contrast, under all conditions examined
(low and high enzyme concentrations; short or long reaction
times), the TarFBs reaction produces a smear of radioactivityureus
e 4b in the presence of heat-treated () or active enzyme (+). Tabulatedmasses
110, October 29 , 2010 ª2010 Elsevier Ltd All rights reserved 1103
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Pathway for B. subtilis W23 WTA Biosynthesiswithout a distinct banding pattern. These results suggested the
formation of multiple products. Reactions with TarFBs and
substrates 1 and 4a were carried out using nonradiolabeled
substrates and subjected to Q-TOF MS analysis. Discrete prod-
ucts with increasing numbers of GroPs up to 9 units were
detected. Thus, whereas TarFSa is a primase that preferentially
adds a single GroP unit to 4, TarFBs behaves as a polymerase,
adding GroP units to 4 in rapid succession up to a detectable
length of at least 9 units.
Reconstitution of B. subtilisW23 TarK and TarL
Lazarevic et al. (2002) proposed that TarK (TarKBs) and TarL
(TarLBs) from B. subtilis W23 form a primase-polymerase pair,
with the former transferring a single ribitol-phosphate unit to
the TarFBs product and the latter adding multiple ribitol-phos-
phate units to build the polymer chain (Figure 1C). Using a
heterologous complementation approach, we have previously
provided evidence that B. subtilis W23 TarK and TarL function
as a primase-polymerase pair because both are required to
complement the deletion of S. aureus TarL, which combines
both functions (Meredith et al., 2008; Pereira et al., 2008a).
However, the genetic complementation experiments did not
provide detailed information on the enzymatic reactions carried
out by TarKBs and TarLBs. Here, we have reconstituted the
in vitro activities of these enzymes to characterize their substrate
preferences and verify their proposed products.
TarKBs and TarLBs were cloned from genomic B. subtilis W23
DNA, expressed as C-terminal 6-His fusion proteins and purified
by nickel chromatography. WTAs extracted from B. subtilisW23
cells are reported to contain 1–2 GroP units, and because TarKBs
is a proposed ribitol-phosphate phosphotransferase, we first
tested the activity of TarKBs with CDP-ribitol (2) and WTA
intermediate 4a, which contains 1 GroP unit. The reaction was
analyzed by HPLC because products could not be resolved by
polyacrylamide gel electrophoresis (Figure S3A). A decrease in
the CDP-ribitol peak, accompanied by the appearance of
CMP, showed that TarKBs reacts with CDP-ribitol in the
presence of 4a. We also tested the activity of TarKBs with 4a
and CDP-glycerol (1). An unchanged peak area for CDP-glycerol
with no appearance of CMP showed that TarKBs does not utilize
1 as a donor.
Exact mass analysis of a TarKBs reaction of 2 with 4a showed
that the predominant product, compound 7a, contained 1 ribitol-
phosphate unit (m/z [M-H]- expected: 1087.2472, actual:
1087.2509); a small amount of product (mass abundance less
than 0.05% compared with compound 7a) containing 2 ribitol-
phosphate units was also detected (m/z [M-H]- expected:
1301.2715, actual: 1301.2591). The MS data and HPLC traces
confirm that TarK from B. subtilis W23 is a ribitol-phosphate
primase that catalyzes the addition of a ribitol-phosphate unit
from CDP-ribitol to WTA intermediate 4 to form lipid-pp-
GlcNAc-ManNAc-GroP-RboP (7).
To evaluate the substrate specificity of TarKBs in more detail,
we carried out tandem reactions of B. subtilis TarK and TarL.
Tandem reactions were used to enable product analysis by
PAGE because the TarK products cannot be resolved from start-
ing material. TarKBs and TarLBs were incubated with CDP-ribitol
(2) and radiolabeled lipid intermediates 4b, 5b, and 6b. These
intermediates differ in the number of glycerol phosphates1104 Chemistry & Biology 17, 1101–1110, October 29 , 2010 ª2010 Eappended to the ManNAc sugar. Reactions were analyzed for
the appearance of polymeric product (Figure 4A). The TarKBs/
TarLBs tandem reaction converted substrate 4b to polymeric
product. Tandem reactions using substrates containing more
than 1 GroP unit (e.g., 5b or 6b) resulted in little to no WTA
polymer.
To confirm that the resulting polymeric products observed in
the TarKBs/TarLBs reactions were due to a tandem reaction of
TarKBs acting as a primase and then TarLBs acting as a poly-
merase, we tested the ability of B. subtilis W23 TarL to catalyze
the addition of ribitol-phosphate units to different WTA interme-
diates. TarLBs was incubated with 4b, 5b, 6b, or 7b in the pres-
ence of CDP-ribitol (2). The reaction products were analyzed by
PAGE (Figure 4B; Figure S4A). No radioactive products were
observed for reactions containing lipid substrates 4b, 5b, or
6b, showing that TarLBs is unable to use any of the GroP primed
intermediates to make polymer. In contrast the enzymatic reac-
tion with compound 7b showed the disappearance of starting
material and the appearance of a smear of radioactivity corre-
sponding to higher molecular weight products. The gel analysis
shows that TarLBs reacts with the ribitol-phosphate-primed
substrate and is consistent with the addition of multiple RboP
subunits. These data confirm that TarLBs is a ribitol-phosphate
polymerase and that it requires for reaction a ribitol-phos-
phate-primed substrate produced by TarKBs.
The TarKBs/TarLBs tandem reactions showed that TarKBs
has a strong preference for substrate 4, but it was not
clear whether the small amount of polymeric product ob-
served in the middle panel of Figure 4A resulted from the reac-
tion of TarKBs with 5b or with contaminating 4b because the
starting material was estimated to be only 90% pure, and the
impurity could not easily be removed. Therefore, we incubated
TarKBs with CDP-ribitol (2) and a mixture of 4a and 5a and
analyzed the products by Q-TOF MS. The major peak proved
to be unreacted lipid-pp-GlcNAc-ManNAc-GroP2 (compound
5a) (m/z [M-H]- expected: 1027.2261, actual: 1027.2264).
Another peak corresponding to compound 7a (m/z [M-H]-
expected: 1087.2472, actual: 1087.2468) was detected, result-
ing from TarKBs utilizing 4a as a substrate. We were unable to
detect any product peak corresponding to the addition of
RboP to 5a. These results imply that TarKBs is only able to
accept lipid-pp-GlcNAc-ManNAc-GroP (4), the TagB product,
as a substrate and that the small amount of polymeric
product observed in the middle panel of Figure 4A is due to
a reaction with the small amount of substrate 4 in the starting
material.
The results described in the previous paragraph confirm that
TarKBs and TarLBs comprise a RboP primase-polymerase pair
and carry out the reactions shown in Figure 4C. These reactions
are not consistent with the model shown in Figure 1C (Lazarevic
et al., 2002). In that model, TarFBs acts as a primase to synthe-
size a lipid-GlcNAc-ManNAc-GroP2 substrate for TarKBs, but
our results show that TarKBs acts only on the TagB product,
which contains a single GroP unit. Because TarKBs is unable to
accept WTA intermediates containing more than a single GroP
unit, and because TarFBs is a polymerase that adds multiple
GroP units to 4, we surmised that TarFBs could not be on the
pathway to polyribitol WTA formation in B. subtilis W23. If this
supposition is correct, then one would predict that B. subtilislsevier Ltd All rights reserved
Figure 4. TarK and TarL React Sequentially on the TarB Product (4)
(A) PAGE analysis of a tandem TarKBs/TarLBs reaction using either heat-treated () or active (+) enzymes incubated with CDP-ribitol and 4b, 5b, or 6b. The poly-
meric material in the middle panel is due to reaction with contaminating 4b. Polymer product only forms when 4b is used as the starting material (see text).
(B) PAGE analysis of TarLBs heat-treated () or active (+) enzyme incubated with 4b or 7b and CDP-ribitol (2). TarLBs reacts only with 7b. See also Figure S4.
(C) Reactions carried out by TarKBs and TarLBs with CDP-ribitol (2) and substrates 4 and 7, respectively.
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Pathway for B. subtilis W23 WTA BiosynthesistarF can be deleted, and polyribitol-phosphate WTAs will still be
produced in strains containing theB. subtilis TarK-TarL primase-
polymerase pair.
TarF Is Dispensable for Polyribitol-Phosphate WTA
Synthesis in Pathways Containing a TarK Primase
To test the predicted dispensability of B. subtilis TarF in strains
expressing B. subtilis TarK and TarL, we deleted tarF from two
different strains expressing these B. subtilis enzymes. The first
strainwas anS. aureus hybrid strain (JT215) containingB. subtilis
TarK-TarL in place of the native bifunctional S. aureus enzymes
(TarL or TarL’) (Meredith et al., 2008). This hybrid strain contains
the native S. aureus tarF, which is essential in the wild-type
S. aureus background (D’Elia et al., 2006b). Despite its essenti-
ality in the wild-type background, we were able to delete tarF
from the hybrid S. aureus strain. In fact the DtarF deletionChemistry & Biology 17, 1101–1allele was almost exclusively observed upon resolving the inte-
grated tarF deletion vector, and the doubling time of the DtarF
hybrid strain was faster than that of the hybrid parent strain,
suggesting that the removal of TarF actually increases strain
fitness.We confirmed thatWTAs extracted from theDtarF hybrid
strain are identical in length and banding pattern to those ex-
tracted from the parent strain (Figure 5C). Thus, replacing
S. aureus TarL with TarKBs-TarLBs renders S. aureus TarF
dispensable for polyRboP-WTA synthesis in an S. aureus back-
ground.
We next constructed a marked tarF deletion in a wild-type B.
subtilisW23 strain containing only the nativeB. subtilis enzymes.
The DtarF strain (DM1) had a similar growth rate as the parent
strain, and the colony morphology was unchanged (Figures 5A
and 5B). There were no apparent differences in the amounts of
extracted WTAs in the DtarF and parent strains. Furthermore,110, October 29 , 2010 ª2010 Elsevier Ltd All rights reserved 1105
Figure 5. TarKBs and TarLBs Make polyRboP-WTAs
In Vivo in the Absence of TarFBs
(A) Growth curves of B. subtilis W23 wild-type (WT) or DtarF
strains.
(B) Photograph of bacterial colonies of B. subtilis W23 wild-
type (WT) or DtarF strains.
(C and D) WTAs of the parent wild-type strain or the DtarF
strain extracted from the B. subtilis/S. aureus hybrid strain
JT215 (C) or B. subtilis W23 (D) analyzed by PAGE analysis
and Alcian blue/silver staining.
(E) Agarose gel analysis of PCR-amplified fragments from B.
subtilis W23 cDNA or genomic DNA (positive control). (+)
and () indicate the presence or absence of reverse transcrip-
tase during cDNA synthesis. The sizes of the amplified frag-
ments are 170 bp (tarK), 159 bp (tarF), and 68 bp (16S rRNA)
(internal control).
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Pathway for B. subtilis W23 WTA BiosynthesisWTAs extracted from the two strains were indistinguishable by
PAGE analysis (Figure 5D). Degradation of extracted WTAs
from each strain followed by Q-TOF MS analysis confirmed
that in both strains the subunits of the main chain polymer are
composed of ribitol-phosphates covalently modified with
glucose (m/z [M-H]- expected: 393.0804; actual wild-type:
393.0813, DtarF: 393.0811) (Figure S5). These deletion experi-
ments are fully consistent with the in vitro experiments showing
that TarKBs reacts preferentially with the TagB product, and not
with intermediates containing additional GroP units. Thus,
genetic studies in two different strain backgrounds confirm the
biochemical work showing that TarFBs is not on the pathway to
polyRboP WTAs in B. subtilis W23.
B. subtilis tarF Is Not Expressed during
Exponential Growth
We have shown that tarFBs, which is located within the WTA
biosynthetic gene cluster, encodes a functional enzyme that
makes short GroP-WTA polymers, but it is not involved in
polyRboP WTA synthesis. Because it has been reported that
strains in the W23 group (Nakamura et al., 1999), S. xylosus,
S. saprophyticus (Endl et al., 1983, 1984), and an S. aureus
biofilm-producing strain (Vinogradov et al., 2006) produce both
ribitol-phosphate and GroPWTAs, we considered the possibility
that B. subtilis W23 might contain a small proportion of poly-
GroP-WTAs. We were unable to confirm the presence of GroP-
WTAs by MS analysis of WTAs extracted from B. subtilis W23
(the detection limit is 5 pmol), so we attempted to generate dele-
tions of tarK in B. subtilis W23 to determine whether TarFBs was1106 Chemistry & Biology 17, 1101–1110, October 29 , 2010 ª2010 Elsevier Ltd Alcapable of making polyGroP-WTAs in a DtarK
background. All efforts to delete tarK were unsuc-
cessful, suggesting that this gene, unlike tarF, is
essential in B. subtilis W23. Therefore, we exam-
ined the relative levels of tarF and tarK gene
expression using RT-PCR. Under normal labora-
tory conditions, the tarF transcript is barely detect-
able in cells harvested during late exponential
growth, whereas the tarK transcript is abundant
(Figure 5E). Increased amounts of template cDNA
in the PCR reaction did not change the levels of
detectable transcript. Although TarFBs is a func-
tional enzyme, it is not expressed under normallaboratory growth conditions. Its cellular function, if any, remains
a mystery, but it is not involved in polyRboP-WTA biosynthesis.
DISCUSSION
WTAs comprise a large fraction of the Gram-positive cell wall.
They play important roles in cell envelope integrity, and there
is increasing evidence that they are involved in fundamental
aspects of cell growth and division (Xia et al., 2009). Under-
standing how these polymers are made is a necessary step in
dissecting their cellular functions and in exploring their potential
as antimicrobial targets in pathogens such as S. aureus.
Although pathways for polyglycerol-phosphate and polyribitol-
phosphate WTA biosynthesis in B. subtilis were proposed
many years ago (Lazarevic et al., 2002; Ward, 1981), verification
and detailed characterization of the enzymatic steps were not
possible until recently. The development of chemoenzymatic
approaches to obtain functional WTA intermediates has made
the in vitro reconstitution of both individual enzymes and entire
pathways for WTA biosynthesis feasible (Brown et al., 2008;
Ginsberg et al., 2006; Sewell et al., 2009; Zhang et al., 2006).
In this paper we have carried out an extensive biochemical
and genetic analysis of polyRboP-WTA synthesis in B. subtilis
W23. Although some steps of the proposed model for poly-
RboP-WTA biosynthesis were confirmed, we have revised
others.
Characterization of the enzymes proposed to be involved in
the late steps of the B. subtilis polyribitol-phosphate WTA
pathway revealed two unexpected results. First, unlike S. aureusl rights reserved
Figure 6. Two Pathways for Polyribitol-
Phosphate WTA Formation in Bacteria
A schematic of the verified late-stage intracellular
steps inWTA biosynthesis in S. aureus andB. sub-
tilis W23.
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Pathway for B. subtilis W23 WTA BiosynthesisTarF,B. subtilis TarF is not a primase. Rather than adding a single
glycerol phosphate unit, it adds several units in rapid succession.
Therefore, it is a polymerase that makes short GroP WTA
polymers. Second, B. subtilis TarK, although it is indeed a phos-
phoribitol primase, acts only on the TagB product. It cannot use
substrates made by B. subtilis TarF, which adds multiple GroP
units. This finding implies that B. subtilis TarF is not on the
pathway to polyRboP-WTAs.
We confirmed this surprising conclusion by first deleting
S. aureus tarF from an S. aureus hybrid strain (Meredith et al.,
2008) expressing the primase-polymerase pair from B. subtilis,
TarKBs/TarLBs. Although S. aureus TarF is essential in a back-
ground containing S. aureus TarL (D’Elia et al., 2006b), we
showed that it is dispensable in a strain containing the comple-
menting B. subtilis enzymes. In fact its deletion in the hybrid
strain appears to confer a modest fitness advantage. A plausible
explanation for the growth advantage of the DtarF S. aureus
strain is that TarF activity impedes the maturation of WTAs
because the product it makes is not a preferred substrate for
the complementing B. subtilis enzymes. We were also able to
delete tarFBs from the B. subtilis W23 wild-type strain without
any apparent effects on growth, colony morphology, or the
production of WTAs. In contrast all similar attempts to delete
tarKBs from B. subtilis W23 failed, suggesting that this gene
cannot be deletedwithout affecting viability. This result is consis-
tent with other studies showing that enzymes required to
complete the WTA main chain are conditionally essential
(D’Elia et al., 2006a, 2006b; Swoboda et al., 2010). The ability
to delete tarFBs, but not tarKBs, supports the hypothesis that
the latter is required for RboP-WTA synthesis, but the former is
not. RT-PCR analysis further supports this hypothesis because
it shows that tarK is expressed at high levels during exponential
growth, whereas tarF transcription is almost undetectable.
The pathways for polyribitol-phosphate WTA biosynthesis in
B. subtilis W23 and S. aureus are now established, as shown in
Figure 6. These pathways proceed through the same three initial
steps and result in the formation of a lipid-diphospho-GlcNAc-Chemistry & Biology 17, 1101–1110, October 29 , 2010 ªManNAc-phosphoglycerol unit (4) (Bhav-
sar et al., 2005; Ginsberg et al., 2006;
Soldo et al., 2002; Zhang et al., 2006).
Following the third step, catalyzed by
TagB, the B. subtilis W23 and S. aureus
pathways diverge. B. subtilis W23 uses
a RboP primase (TarK) followed by an
RboP polymerase (TarLBs) to complete
the WTA main chain; S. aureus uses a
GroP primase (TarF) followed by a bifunc-
tional RboP primase/polymerase (TarLSa)
to complete the chain. The revised path-
ways, shown in Figure 6, are in line with
previously reported data by Yokoyamaet al. (1986) on the isolation of WTA intermediates from B. subtilis
W23 and S. aureus.
In addition to establishing the pathways for polyribitol-phos-
phate WTA polymer synthesis, we note that this work highlights
the enzymatic diversity of the large family of CDP-phosphotrans-
ferases involved in WTA biosynthesis. These enzymes include
both GroP and RboP primases and polymerases, and it does
not yet appear possible to predict their functions or substrate
preferences accurately based on protein sequences (Figure S6).
For example, S. aureus TarF is a GroP primase that adds 1 GroP
subunit to the linkage unit, whereasB. subtilis 168 TagF is a GroP
polymerase that adds 45–60 GroP units (Pereira et al., 2008b).
B. subtilisW23 TarF makes short GroP polymers in vitro, adding
about eight GroPs to the linkage unit. The RboP transferases are
similarly diverse, with the primase TarKBs having stringent spec-
ificity for singly GroP-primed substrates and the sequence-
related polymerase TarLBs having similarly stringent specificity
for RboP-primed substrates, whereas S. aureus TarL functions
both as an RboP primase and polymerase and is selective for
doubly GroP-primed substrates. The first structure of a member
of this diverse family of phosphotransferases was recently
reported (Staphylococcus epidermidis TagF) (Lovering et al.,
2010), and it may, when combined with accurate information
about enzymatic function, facilitate the identification of the
features that determine which substrates are selected or
whether a particular enzyme functions as a primase or a poly-
merase. In closing we note that there is a strong argument to
be made for a new systematic nomenclature to designate the
CDP-phosphotransferases involved in WTA biosynthesis now
that the diversity of enzymatic function has been recognized,
and the first ascribed gene names do not accurately describe
these functions.
SIGNIFICANCE
WTAs are important cell surface polymers in many Gram-
positive organisms, both pathogens and nonpathogens2010 Elsevier Ltd All rights reserved 1107
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morphology, adhesion, and envelope integrity. Under-
standing how they are made is important for conducting
detailed studies of their cellular functions (Swoboda et al.,
2010). We have developed chemoenzymatic approaches to
obtain WTA intermediates to enable the detailed enzymatic
characterization of WTA biosynthesis. Here, we have used
an extensive set of purified WTA intermediates to compare
the pathways for polyribitol-phosphate WTA synthesis in
B. subtilisW23 andS. aureus. We show that these organisms
use different sets of enzymes to make similar WTA
polymers. Hence, bacteria employ two distinct pathways
to make polyribitol-phosphate WTAs as outlined in Figure 6.
This work should facilitate continued efforts to predict tei-
choic acid gene functions and determine pathway order in
sequenced genomes, will enable well-grounded biological
studies to establish the roles of WTA enzymes in the growth
and division of S. aureus and B. subtilis, and may facilitate
antibiotic discovery.
EXPERIMENTAL PROCEDURES
Materials and Methods
B. subtilis W23 is from ATCC (ATCC 23059). Restriction enzymes were from
New England Biolabs. The plasmid used for cloning, pET-24b(+), and His-Bind
Resin are available from EMDChemicals. PCRwas performed using KODHot-
Start (EMD Chemicals). The pKM074a vector was a generous gift from David
Rudner (Harvard Medical School). Radiolabeled L-[14C]-glycerol-3-phosphate
was purchased from GE Healthcare. All other reagents and chemicals used
were from Sigma. The WTA extraction and analysis by polyacrylamide gel
electrophoresis and Alcian blue/silver staining have been described previously
(Meredith et al., 2008).
Cloning of B. subtilis W23 Genes
The S. aureus enzymes used in this study were cloned, overexpressed, and
purified as described previously (Brown et al., 2008). All primers and strains
are listed in Supplemental Information . The tarF, tarK, and tarL genes were
PCR amplified using B. subtilis W23 genomic DNA as a template and the
primers tarFp24bF and tarFp24bR, tarKp24bF and tarKp24bR, and tarLp24bF
and tarLp24bR. The PCR products were digested with the appropriate restric-
tion enzymes and ligated into a similarly digested pET-24b(+) vector. The con-
structed plasmids were verified by restriction digest and DNA sequencing
(Dana-Farber/Harvard Cancer Center DNA Resource Core).
Protein Overexpression and Purification
S. aureus proteins used in this study were overexpressed and purified as
described previously (Brown et al., 2008). TagB from B. subtilis 168 was
used to construct various WTA intermediates and was overexpressed and
purified as described previously (Ginsberg et al., 2006). All constructed Tar
protein-pET-24b plasmids were transformed into Rosetta2(DE3)pLysS cells
for overexpression with IPTG. The cell pellets were lysed with rLysozyme
and benzonase in 100 mM Tris HCl (pH 7.5), 500 mM NaCl, 0.6% CHAPS,
and 5% glycerol. The clarified lysate was purified over charged nickel His-
Bind resin. More detailed procedures can be found in Supplemental
Experimental Procedures. The proteins were stored as 50% glycerol stocks
at either 20C or 80C. The yield is approximately 5 mg/l for TarFBs,
10 mg/l for TarKBs, and 4 mg/l for TarLBs.
Construction of WTA Intermediates
Radiolabeled [14C]-CDP-glycerol (1) was prepared as described previously
using TarD (Badurina et al., 2003). CDP-ribitol (2) was prepared as described
previously (Brown et al., 2008; Pereira and Brown, 2004). Due to issues with
degradation upon long-term storage, CDP-ribitol was purified by HPLC after
chemoenzymatic synthesis using a strong anion exchange column from
Phenomenex (Phenosphere SAX 80A, 250 3 4.6 mm 5 m). For purification1108 Chemistry & Biology 17, 1101–1110, October 29 , 2010 ª2010 Edetails, see Supplemental Experimental Procedures. WTA intermediates 3,
4, and 5 were prepared as described previously (Brown et al., 2008).
To prepared radiolabeled compound 6b, an enzymatic reaction (30 ml) contain-
ing 2 mM TagB, 2 mM TarFSa, 20 mM of purified 3b, and 80 mM [
14C]-CDP-glyc-
erol were incubated in 20 mM Tris (pH 7.5), 100 mM NaCl, and 10 mM MgCl2
for 30 min at room temperature. This allows formation of intermediate 5b.
TarFBs (2 mM) was then added to utilize the remaining [
14C]-CDP-glycerol to
form compound 6b. 6bwas purified using a Phenomenex Strata X 33 mmpoly-
meric reversed phase (30 mg/1 ml) column. To prepare radiolabeled
compound 7b, a 30 ml reaction containing 500 nM TagB, 500 nM TarFSa,
5 mM TarKBs, 50 mM of purified 3b, 100 mM of [
14C]-CDP-glycerol, and
100 mM of CDP-glycerol was incubated in 20 mM Tris (pH 7.5), 100 mM
NaCl, and 30 mM MgCl2 for 2 hr at room temperature. The reaction was puri-
fied as described for compound 6b. Cold reactions performed simultaneously
and analyzed by LC/MS confirmed the formation of compounds 6 and 7.
HPLC Analysis of TarK Reactions
For HPLC analysis a Phenomenex Phenosphere SAX 80 A, 250 3 4.6 mm 5 m
strong anion exchange column was used on an Agilent 1100 HPLC at flow rate
of 1 ml/min with a linear gradient of 0%–20% B over 15 min (buffer A: 5 mM
ammonium acetate [pH 3.8]; buffer B: 750 mM ammonium dihydrogen phos-
phate [pH 3.7]). The UV signal was monitored at 271 nM. TarKBs (30 ml) reac-
tions contained 200 mM 4a, 200 mM 1 or 2, and 1 mM enzyme in 20 mM Tris
(pH 7.5), 100 mM NaCl, and 10mM MgCl2. After 30 min at room temperature,
the reactions were quenched with 30 ml methanol and analyzed by HPLC.
Reactions containing heat-treated enzymes served as negative controls.
PAGE Analysis of Enzymatic Reactions
To assay TarFBs substrate specificity, reactions (3 ml) contained 500 nM or
5 mM enzyme, 1 mM 4b, and 6 mM of either 2 or [14C]-1 in a buffer of 100 mM
NaCl, 20 mM Tris (pH 7.5), and 10 mM MgCl2. A reaction was also set up
with 2 mM 3b and 2 mM [14C]-1. Heat-treated enzyme served as a negative
control. Reactions were quenched after 3 hr with 3 ml DMF. Two microliters
of 43 loading dye (80% glycerol, 0.02% bromophenol blue) was added, and
4 ml of the mixture was loaded on a 7 3 8 3 0.1 cm, 0.25 M TBE/20% acryl-
amide gel (preparation described previously [Brown et al., 2008]). The gel
was electrophoresed at 100 V for 110 min, dried, exposed to a phosphor
screen, and analyzed by radiometry.
TarF reactions (3 ml) were performed using 500 nM enzyme (S. aureus or B.
subtilisW23) with 3 mM 4b, 18 mM [14C]-1, and 18 mM 1 in 100mMNaCl, 20mM
Tris (pH 7.5), and 10 mMMgCl2. Reactions were quenched with 3 ml DMF after
30 min or 12 hr at room temperature. Reactions containing the same compo-
sition, but with 2 mM enzyme, were allowed to proceed for 12 hr at room
temperature. Identical reactions using heat-treated enzyme served as nega-
tive controls. Two microliters of 43 loading dye was added, and 8 ml of the
mixture was loaded on a 16 3 16 3 0.1 cm 0.25 M TBE/20% acrylamide
gel. After running for 260 min at 225 V, the gel was dried, exposed to phosphor
screen, and analyzed by radiometry.
TarLBs reactions (3 ml) were performed using 5 mM enzyme with 2 mM 4b, 5b,
6b, or 7b and 200 mM 2. TarKBs reacting in tandem with TarLBs (3 ml reactions)
contained 1 mM of each enzyme with 2 mM 4b, 5b, or 6b and 200 mM 2. Reac-
tion buffer was 100 mM NaCl, 20 mM Tris (pH 7.5), and 30 mM MgCl2. Each
substrate combination was also incubated with a heat-treated enzyme to
serve as a negative control. After 2 hr at room temperature, the reactions
were quenched with 3ml DMF and analyzed as described for TarFBs substrate
specificity reactions.
Q-TOF LC/MS Analysis
All analyses were performed on an Agilent 6520 Q-TOF LC/MS using
a Phenomenex Gemini 5 micron C18 100 A column (50 3 4.6 mm) at a flow
rate of 1 ml/min (solvent A: water; solvent B: methanol both with 0.1% ammo-
nium hydroxide as a solvent modifier), with a linear gradient from 0% to 100%
B over 10 min. Detailed reaction conditions and purification procedures are
located in Supplemental Experimental Procedures.
Construction of S. aureus tarF Deletion Strain
The tarF deletion cassette was obtained by assembly PCR of two amplicons
encoding approximately 1 kB DNA regions flanking the tarF open readinglsevier Ltd All rights reserved
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pKOR1 (digested with ApaI/EcoRV) to generate pKOR1-223. The deletion
vector was introduced into strain JT215 by electroporation (Schenk and
Laddaga, 1992), and the tarF deletion strain JT230 was subsequently isolated
by double crossover as described (Meredith et al., 2008).
Construction of B. subtilis W23 tarF Deletion Strain
The marked tarF gene deletion in B. subtilis W23 was made using a protocol
developed for B. subtilis 168 gene deletion (Jarmer et al., 2002). Assembly
of the linear fragment, Z, containing the CAT cassette flanked by 1 kB DNA
flanking of B. subtilis W23 tarF is described in Supplemental Experimental
Procedures. The B. subtilis W23 strain to be transformed was streaked on
LB/agar and grown overnight at 37C. A single colony was used to inoculate
a 5 ml culture of B. subtilis W23 and grown overnight at 37C in modified
Spizizen minimal salt medium with glutamate (Jarmer et al., 2002). At OD450
1, 50 ml of cells was diluted into 5 ml of fresh minimal media and grown at
37C. At OD450 0.6, 200 ml of cells was incubated with at least 2 mg of linear
DNA Z. After 2 hr shaking at 37C, the cells were plated on LB/agar containing
5 mg/ml chloramphenicol and incubated overnight at 37C. Amarked tarF gene
deletion was confirmed by PCR analysis using primers that anneal outside the
deletion region.
WTA Extraction and Degradation
WTAs were extracted and broken into monomeric units following a combina-
tion of previously published protocols (Bernal et al., 2009; Sadovskaya et al.,
2004; Tomita et al., 2009; Wickham et al., 2009). A detailed protocol can be
found in Supplemental Experimental Procedures. Briefly, the cell pellet was
disrupted by sonication. Noncovalently bound components were removed
from the cell wall by incubation with SDS, and covalently bound protein and
nucleic acids were removed by treatment with trypsin, DNase, and RNase.
The WTA was extracted by 10% trichloroacetic acid. Following centrifugation
to remove peptidoglycan, the WTAs were precipitated in 95% ethanol.
To prepare monomeric units, the WTAs were treated with 1 N NaOH at
100C for 3 hr. The yield was between 5 and 9 mg from 500 ml cultures. The
monomeric units were analyzed by Q-TOF MS using direct inject with Solvent
A (described previously) at a flow rate of 0.2 ml/min.
RT-PCR
Three milliliters of B. subtilisW23 culture at an OD600 of0.8 was harvested by
centrifugation, resuspended in RNALater reagent (QIAGEN), and stored
at 20C until further use. RNA was extracted from the cell pellets using the
QIAGEN RNeasy Mini Kit with an initial treatment of 0.3 mg/ml lysostaphin
and 100 mg/ml Proteinase K. RQ1 DNase (Promega) was used to degrade
DNA. Four hundred nanograms of RNA was reverse transcribed using Super-
Script III Reverse Transcriptase (Invitrogen) using random hexamer primers.
RNA without reverse transcriptase treatment was used to detect potential
DNA contamination. Of this reaction, 0.3–5 ml was used as template for PCR
using KOD Hot Start (Novagen). Amplification of a fragment of the 16 s rRNA
transcript was used as an internal reference to ensure equal amounts of
cDNA template in each PCR reaction. RT-PCR was performed in both biolog-
ical and analytical duplicate. PCR of B. subtilis W23 genomic DNA was
performed to confirm that the primers were able to amplify the desired frag-
ment of cDNA. PCRproducts were analyzed by electrophoresis on an ethidium
bromide stained 2% agarose gel. The primers used are listed in Supplemental
Experimental Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
six figures, and two tables and can be found with this article online at doi:10.
1016/j.chembiol.2010.07.017.
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